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Abstract: Human papillomaviruses (HPVs) seem to play an important role in the pathogenesis of gynecological 
carcinomas and in head and neck carcinomas. The aim of this study was to detect and genotype HPVs in fresh oral 
squamous cell carcinoma (OSCC) from a Sardinian population, and to determine whether HPV presence was significantly 
associated with the development of OSCC. 
The oral mucosa tissues were obtained from 120 samples (68 OSCC and 52 control samples) taken from a Sardinian 
population seen at the Dental Clinic of the Department of Surgery and Odontostomatological Sciences, University of 
Cagliari (Italy) and the “ Ospedale SS Trinità”, Cagliari (A.S.L. 8) between 2007 and 2008. PCR was used for the 
detection of HPV DNA and the genotype was determined by DNA sequencing. The frequency of HPV infection was 
evaluated in relation to age, sex, smoking and alcohol use. Statistical analysis was performed using the SPSS 11.5 
software. 
The results showed the presence of HPV-DNA in 60.3% of OSCC with HPV-16 (51.2%) being the most frequent 
genotype. In these Sardinian OSCC patients, HPV-DNA was detected more in males (65.8%) than in females (34.1%) 
while controls show a 0% of HPV presence. HPV positive was highly associated with OSCC among subjects with a 
history of heavy tobacco and alcohol use and among those with no such history. 
A greater frequency of high risk HPV presence was observed in patients with OSCC compared to health control patients. 
In addition these results suggested that oral HPV presence could be associated in OSCC subjects. Our results need more 
analyses to detect the HPV-DNA integration into tumoral cells. 
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INTRODUCTION 
 Squamous cell carcinoma (SCC) is the most common 
malignant tumor of the oral cavity and one of the ten most 
common causes of death. In addition the incidence of oral 
squamous cell carcinoma (OSCC) of the oral cavity and 
oropharynx is increasing worldwide [1]. The annual 
incidence and mortality rates vary considerably between 
different races, genders, and age groups; however, as 
reported in previous publications, the risk of intra-oral 
cancer rises with increasing age especially for males [1-4]. 
Many risk factors have been reported by different authors 
such as: tobacco use and alcohol consumption which are the 
main risk factors for this group of cancer [5]. However, these 
cancers also occur among lifelong tobacco and alcohol 
abstainers and, thus, other risk factors such as conditions 
related to oral health and hygiene (i.e. poor condition of the 
mouth, dentition, bleeding gums, and mouthwash use) have 
been suspected as contributing to its etiology. 
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 In this context, Human papillomavirus (HPV) as a 
prognostic risk for OSSC has not yet been extensively 
studied, a reason for this “defect” could be due to: (i) 
unusual or less sensitive technologies for HPV detection in 
SSC, (ii) in excess of 100 HPV genotypes are recognized 
based on specific DNA sequence variations and 30-40 are 
associated with sexual lesions. However, the oncogenic 
capacity of individual HPV types differs considerably [6-8]. 
This virus is epitheliotropic and in humans is associated with 
papillomatosis, hyperplastic, and verrucous lesions on the 
skin and mucous membranes of various sites [9]. These 
genotypes, which are frequently identified in cellular 
neoplasm, have been segregated into those with a low risk 
and those with a high risk of malignant transformation [10]. 
Indeed, some authors have shown that high-risk viral 
genotypes such as HPV 16, 18, 31 and 33, are frequently 
associated with leukoplakia and squamous carcinoma [11, 
12]. On the contrary low-risk types, such as HPV 6, 11, 13, 
32 are preferentially associated with benign proliferative 
epithelial lesions e.g. squamous papilloma, condyloma 
acuminatum, verruca vulgaris and focal epithelial 
hyperplasia [13]. Functionally high-risk HPV infection 
contributes to carcinogenesis and tumor progression through 
two viral oncogenes E6 and E7 [9]. These oncogenes inhibit 
the activities of the p53 and pRb, and, have been considered  
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as an important feature in disrupting cell-cycle regulatory 
pathways leading to a genetic progression to oral squamous 
cell carcinoma (OSCC) [14]. 
 The frequency of HPV in oral lesions varies with 
geographic occurrence [15], the type of lesion [16] and the 
diagnostic methodology [17]. The diagnosis of HPV 
infection is based on the use of advanced molecular tools 
[18]. Polymerase chain reaction (PCR) and sequencing are 
considered the most sensitive and rapid methods for the 
detection and genotyping of HPV-DNA, respectively [19-
21]. 
 The present study was conducted to investigate the 
distribution of HPV in Sardinian patients with malignant oral 
mucosal lesions compared with healthy patients. An 
association between HPV-16, HPV -31 exposure and OSCC 
was also evaluated among subjects with different use of 
tobacco and alcohol. 
MATERIALS AND METHODOLOGY 
Clinical Samples 
 The oral mucosa fresh tissues were obtained from 120 
samples (mean age 61.4, age range: 22-86, 69 men and 51 
women). Sixty-eight were from the patients with OSCC seen 
at the “Ospedale SS Trinità”, Cagliari (A.S.L. 8) between 
2007 and 2008. Fifty-two control samples were from 
volunteers randomly chosen from patients at the Department 
of Dental Disease Prevention (University of Cagliari). These 
controls reported no history of cancer or showed no sign of 
mucosal lesions or relevant systemic disease. At the time of 
examination, all participants were informed about the 
research and its purpose and gave their informed consent. 
 An incisional biopsy of the oral squamous cell carcinoma 
(OSCC) lesion was performed on each patient. All biopsies 
were divided into two parts: one part was used for 
histopathological analysis and the other was frozen at -80°C 
until a molecular assay could be performed. Each fresh 
specimen sample was analyzed and histopathologically 
classified as regards to OSCC. Information on patient 
gender, age, smoking and alcohol history was collected from 
direct patient interviews and medical records. Tumor grade 
and staging system (TNM) were obtained from clinical 
notes, histopathology and radiology reports. Staging was 
carried out according to the Fifth Edition of the International 
Cancer Union guidelines [22]. 
Extraction, Amplification and Sequencing 
 About 25 mg of tissue was finely crushed and the DNA 
was extracted with a QIAamp® DNA Mini Kit (Qiagen) 
according to the manufacturer’s instructions, quantified by 
spectrophotometry and frozen at -80°C until use. The 
molecular method for the detection of HPV-DNA was 
Seminested PCR. In the first reaction the degenerate primers 
MY09 (5’-CGT CC(AC) AA(AG) GGA (AT)AC TGA TC-
3’) and MY11 (5’-GC(AC) CAG GG(AT) CAT AA(CT) 
AAT GG-3’) were used to amplify a 450 bp fragment in the 
L1 gene [23]. The first reaction was performed in a final 
volume of 25 ul, consisting of 4 ul extracted DNA as a 
template (100 ng), 2.5 ul of a 10X PCR buffer (200 mM 
Tris-HCl, 500 mM KCl, pH 8.4), 1.5 mM magnesium 
chloride, a deoxyribonucleotide triphosphate mixture (0.2 
mM of each), 0.5 uM of each primers, 2.5 ul U Platinum Taq 
DNA Polymerase and 4 ul of the Rnasi Dnasi-free template. 
All reagents were purchased from Invitrogen (Milan, Italy) 
with the exception of the primers. The mixture was 
incubated for 2 minutes at 95°C and subjected to 20 cycles 
of amplification (95°C for 30 seconds, 52°C (MY09/MY11) 
for 1 minute; and 72°C for 30 seconds) with a final extension 
at 72°C for 5 minutes in a thermal cycler (Eppendorf, Milan, 
Italy). Two micro-liters of the PCR product of the first 
reaction were taken for the PCR second round, with the 
primer MY09 in conjunction with a new second primer, 
GP5+N (5’-TTTGTTACTGTGGTAGATAC-3’) to 
reamplify the material generated in the first round, thus 
generating a 407 base pair fragment. The second reaction 
was performed in a final volume of 25 ul and contained 2.5 
ul of a 10X PCR buffer (200 mM Tris-HCl, 500 mM KCl, 
pH 8.4), 1.0 mM magnesium chloride, a deoxyribonucleotide 
triphosphate mixture (0.2 mM of each), 0.5 uM of each 
primers and 2.5 ul U Platinum Taq DNA Polymerase. Initial 
denaturation for 2 minutes at 95°C was followed by 40 
cycles. Each of the cycles consisted of denaturation for 30 
seconds at 94°C, annealing for 30 seconds at 47°C and chain 
elongation for 1 minute at 72°C. One cycle of chain 
elongation was took for 7 minutes at 72°C at the end. The 
PCR products were electrophoresed on 2% agarose gels, 
stained with sybr green 1.5% and visualized under an 
ultraviolet transilluminator. The beta-globin gene was 
detected (data not shown) in all specimens to confirm the 
presence of amplifiable DNA in the extracted specimens. 
 PCR products were purified with a QIAquick Purification 
PCR kit (Qiagen, Milan, Italy) and were sequenced by a 
conventional capillary ABI Prism 310 automatic sequencer 
(Applied Biosystems Foster City, Calif.). The results were 
edited and analyzed with a Basic Local Alignment Search 
Tool [24]. 
 Statistical analysis was performed using the SPSS 11.5 
software. Data are expressed as the number of percentages 
detected. All data were compared using the Chi-Square and 
Fisher exact with significance considered to be P < 0.05. 
RESULTS 
 HPV-DNA was detected in 120 tissue samples: 68 oral 
squamous cell carcinoma and 52 control samples. The age of 
the patients with OSCC ranged from 27-86 (mean age: 65.6), 
with 47 males aged between 35-86 (mean age: 61.4) and 21 
females aged between 27-84 (mean age: 64.9). The age range 
of the control patients was 22-85 (mean age: 56.8); 25 males 
were aged between 40-85 (mean age 57.5) and 27 females 
between 22-84 (mean age 56.3). Table 1 summarizes the 
information on HPV-positive patient gender, age. Using the 
Blast program, the HPV sequences obtained from positive 
samples showing a representative nucleotide motif were 
submitted to the DNA data Bank GenBank [24] with the 
following accession numbers: DQ286926, DQ312262, 
DQ312263. 
 Of the 68 OSCC samples 41 (41/68, 60.3%) were 
positive for HPV-DNA and indicated by a 407-bp fragment 
on 2% agarose gel electrophoresis of the PCR products (Fig. 
1). Presence of faint bands was read as partial positives that 
need a confirmation by the sequencing. 
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Table 1. OSCC Positive for HPV DNA 
 
Positive  
Samples 
Age  
Years 
Gender 
HPV  
Type 
Oral  
Lesions 
1 50 M 31 OSCC 
2 53 M 31 OSCC 
3 58 M 31 OSCC 
4 50 M 31 OSCC 
5 63 M 31 OSCC 
6 58 M 31 OSCC 
7 50 F 6 OSCC 
8 66 F 16 OSCC 
9 79 F 16 OSCC 
10 56 M 16 OSCC 
11 72 F 6 OSCC 
12 60 F 16 OSCC 
13 51 F 16 OSCC 
14 76 M 6 OSCC 
15 68 F 16 OSCC 
16 60 M 55 OSCC 
17 80 F 16 OSCC 
18 35 M 16 OSCC 
19 78 M 16 OSCC 
20 61 F 16 OSCC 
21 54 F 16 OSCC 
22 51 F 16 OSCC 
23 39 M 16 OSCC
24 52 F 31 OSCC
25 67 M 16 OSCC
26 58 M 16 OSCC
27 74 M 16 OSCC
28 71 M 16 OSCC
29 73 M 16 OSCC
30 49 M 16 OSCC
31 63 M 16 OSCC
32 74 M 6 OSCC
33 61 M 6 OSCC 
34 65 M 6 OSCC 
35 78 M 6 OSCC 
36 70 M 6 OSCC 
37 84 F 6 OSCC 
38 59 M 16 OSCC 
39 78 M 6 OSCC 
40 72 F 6 OSCC 
41 59 M 6 OSCC 
 
 
DNA from oral tissue was amplified by seminested polymerase chain reaction.  
Fig. (1). This figure shows the amplicon of the second round 
reaction generating a 407 bp fragment on 2% agarose gel 
electrophoresis. Lane 1 is Marker 100 bp, lanes 2, 3, 4 and 5 are 
positive samples confirmed by nucleotide DNA sequencing, lane 6 
is a negative sample. Lane 7 is the positive HPV control and lane 8 
is the negative control. Some sequences of HPV types 6 and 31 
were submitted to the DNA data Bank (GenBank 
http://www.ncbi.nlm.nih.gov/BLAST/) with the following 
accession numbers: DQ286926, DQ312262, DQ312263. The beta-
globin gene was detected (data not shown) in all specimens to 
confirm the presence of amplificable DNA in the extracted 
specimens. 
 Whereas twenty-eight carcinoma samples (28/41, 68.3%) 
were positive for a high-risk subtype (21/41, 51.2% HPV-16 
and 7/41, 17% HPV-31) only 13 samples out of 41 (34.14%) 
were positive for low-risk subtype (12/41, 29.3% HPV-6 and 
1/41, 2.4% HPV-55) (Fig. 2). We were unable to find HPV 
presence in the 52 samples forming the control group. 
Moreover, post hoc analysis showed a significant effect for 
the differences between the OSCC patients and the control 
group (P < 0.05) for the prevalence of HPV-DNA. 
Fig. (2). Frequency in percentage of different HPV genotypes in 
OSCC samples. Samples positive on seminested PCR were 
subjected to nucleotide DNA sequencing. Alignments were 
obtained from the GenBank online BLAST server and HPV 
sequences were downloaded from the HPV database. 
 As regards virus distribution between genders (Fig. 3), 
we observed significant differences in HPV frequency 
between males and females with OSCC from a Sardinian 
population, 65.8% vs 34.1%, respectively. Furthermore, in 
subjects over 50 years, a significant increase in HPV DNA 
(P < 0.05) was detected with advancing age (8% <49 years 
and 92%> 49 years) (Fig. 4). 
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166    The Open Virology Journal, 2010, Volume 4 Montaldo et al. 
 
Fig. (3). Presence in the OSCC human papillomavirus (HPV) in 
relationship to sex, expressed as a frequency percentage. We 
observed significant differences in HPV frequency between males 
and females with OSCC from a Sardinian population, 65.8% vs 
34.1%, respectively. Was not observed the HPV DNA in our 
control group. 
 
Fig. (4). Distribution of HPV in relationship to age, expressed as a 
frequency percentage. Over 50 years of age a significant increase 
HPV DNA of the OSCC samples was found. 
 Table 2 shows the lack of statistical associations between 
the presence of the virus and other known risk factors such 
as smoking and alcohol. We did not observe a significant 
difference between HPV high risk presence and tobacco and 
alcohol use in patients with OSCC. 
Table 2. Samples Positive for HPV High Risk and Tobacco 
and Alcohol Use 
 
 
HPV +,  
High Risk,  
n = 28 
HPV -  
n =27  
P Value 
Tobacco and alcohol use 35 (64.3%) 10 (37.0%) P = 0.351 
Abstain completely from  
Alcohol and tobacco 
10 (35.7.6%) 17 (63%) P = 0.509 
 
DISCUSSION 
 This study was set up to establish the prevalence and 
HPV genotypes in Sardinian patients with OSCC compared 
with a group of healthy patients. According to scientific 
literature, several types of HPV, particularly type 16, have 
been found to be associated with oropharyngeal squamous-
cell carcinoma, a form of head and neck cancer. 
 The role of HPV in the development of uterine cervix 
lesions has been demonstrated by many studies [25]; it still 
remains a controversial issue as regards oral lesions [26-28]. 
Contradictory results reported on HPV infection in oral 
mucosa are mainly due to differences in detection methods 
and the epidemiological characteristics of the observed 
populations [29, 30]. Several reports have indeed utilized 
different molecular techniques (in situ hybridization [31] and 
Southern Blot analysis [32, 33] from several sample 
typologies (mouthwashes, in scrapings and in paraffin-
embedded tissue) [12, 34]. 
 Over the past 20 years, there has been an increasing 
interest in HPVs as regards their potential role in the 
pathogenesis of OSCC [35-41]. Nevertheless, a recent paper 
has confirmed HPV as an independent risk factor for OSCC 
compared to other known factors such as alcohol and 
smoking [42]. Several HPV genotypes (1, 2, 3, 4, 6, 7, 10, 
11, 13, 16, 18, 31, 32, 33, 35, 55, 57) have been isolated 
from oral lesions [12, 43-45]. However, in OSCC, the most 
commonly HPV genotype detected is 16, which has been 
demonstrated in 90-95% of all HPV positive neoplasms, 
followed by HPV 18 and HPV 31 [45-47]. 
 This study was performed on a Sardinian population, 
which presents genetic homogeneity compared to other 
known populations in Europe, including the Italian 
population [48]. Furthermore, a highly sensitive/specific 
molecular methodology such as nested PCR followed by 
capillary sequencing was used [49]. These results confirm 
the prevalence of HPV-DNA in OSCC and also that HPV 16 
is the most frequent genotype. The findings of the present 
study are in agreement with those reported by Miller et al. 
[50] and Anaya-Saavedra et al. [43] in two recent studies, 
suggesting that HPV 16 represents a risk factor in the 
etiopathogenesis of a subset of OSCC. 
 Despite the presence of low-risk, HPV (29.3% HPV-6 
and 2.4% HPV-55) is according to the results of Herrero et 
al. [26] and other authors [44, 51, 52] who have 
demonstrated a malignant degeneration of papillomas 
induced by low-risk HPV. For example Chang et al. [44] 
reported that HPV 6 was also found in squamous cell 
carcinoma. In addition the same bibliographic data showed 
that an association between multiple infection (HPV 6, HPV 
11 and HPV 16) is required for the development of 
malignant lesions [39]. Our results give us the basis to 
further determine how many virus’ presence could be 
fundamental in the carcinogenesis process through the study 
of the HPV DNA integration. 
 In our study we observed a different frequency between 
genders; in fact a major presence of HPV-DNA results in 
males compared to females, as has been described in 
previous studies [53]. Moreover, this finding indicates that 
higher positivity may be the result of accumulated lifetime 
exposure to HPVs. The oral cavity is the anatomic site with 
the most frequent exposure to viruses and we observed an 
increase in HPV positivity with age (Fig. 4) in accordance to 
many papers [47, 54, 55]. This increment may be explained 
by the fact that different factors can be involved in the 
malignant process such as: immune defences [56], nutritional 
deficiencies [57], traumatisms inflicted by fractured teeth, 
incongruous restorations or prostheses [58, 59], and poor 
oral hygiene [60] which worsens with an increase in age. 
Moreover, according to our findings, HPV is a specific risk 
factor for the development of OSCC in association with 
other important risks i.e. smoking and alcohol [61-65]. 
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CONCLUSION 
 Our data support the presence of high frequency of HPV 
16 in oral cancer, but also suggest the possibility of an 
involvement of low-risk HPVs as a cofactor in this 
malignant process; in this context the age of the patients 
plays a central role in the cancer onset. Moreover, the results 
of this study, probably because of small sample size, did not 
show the association significantly among HPV and tobacco 
and alcohol use. Next step, to verify the real HPV role in 
carcinogenesis, will be the study of the possible HPV 
infection determined by the integration in the human genome 
confirmed by the study of E6 and E7 mRNA expression 
[14]. 
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